Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Current Assets:    
Cash $ 6,970,110 $ 8,224,508
Prepaid expenses and other current assets 1,958,280 2,976,583
Total Current Assets 8,928,390 11,201,091
Intangible assets, net 1,658,858 1,948,913
In-process research and development 9,063,000 12,575,780
Goodwill 36,987,886
Total Assets 19,650,248 62,713,670
Current Liabilities:    
Accounts payable 1,801,210 586,611
Accrued expenses 2,284,516 1,964,580
Accrued expenses - related parties 188,159 18,370
Loans payable - current portion 1,308,516 1,828,079
Loans payable - related parties 81,277
Derivative liabilities 75,381 15,220,367
Total Current Liabilities 5,657,782 19,699,284
Loans payable - noncurrent portion 31,189 48,165
Deferred tax liability 2,617,359 3,643,526
Total Liabilities 8,306,330 23,390,975
Commitments and contingencies (Note 11)
Stockholders’ Equity:    
Preferred stock, $0.0001 par value; 5,000,000 shares authorized; (see designations and shares authorized for Series A, Class C and Class K preferred stock)
Class C Preferred Stock; 1 share authorized, issued and outstanding at December 31, 2022 and 2021
Class K Preferred Stock; 1 share authorized, issued and outstanding at December 31, 2022 and 2021
Common stock, $0.0001 par value; 100,000,000 shares authorized; 3,746,906 and 1,701,799 shares issued and outstanding at December 31, 2022 and 2021, respectively 375 170
Additional paid-in capital 121,637,611 107,187,371
Accumulated other comprehensive income (2,885,523) 817,440
Accumulated deficit (107,408,545) (68,682,286)
Total Stockholders’ Equity 11,343,918 39,322,695
Total Liabilities and Stockholders’ Equity $ 19,650,248 $ 62,713,670